Trending Stock News

As Hain Celestial Group (HAIN) Shares Declined, Litespeed Management Has Cut Its Stake; Pfizer (PFE) Stock Value Declined While Gamco Investors Et Al Has Trimmed Holding by $3.28 Million

Pfizer Inc. (NYSE:PFE) Logo

Mario Gabelli decreased its stake in Pfizer Inc (PFE) by 19.09% based on its latest 2017Q4 regulatory filing with the SEC. Gamco Investors Inc Et Al sold 91,095 shares as the company’s stock declined 3.13% with the market. The hedge fund run by Mario Gabelli held 386,031 shares of the health care company at the end of 2017Q4, valued at $13.98 million, down from 477,126 at the end of the previous reported quarter. Gamco Investors Inc Et Al who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $208.48 billion market cap company. The stock decreased 0.20% or $0.07 during the last trading session, reaching $35.64. About 14.93 million shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since May 20, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Jamie Zimmerman decreased its stake in Hain Celestial Group Inc. (HAIN) by 14.96% based on its latest 2017Q4 regulatory filing with the SEC. Litespeed Management Llc sold 117,000 shares as the company’s stock declined 23.03% with the market. The hedge fund run by Jamie Zimmerman held 665,282 shares of the consumer non-durables company at the end of 2017Q4, valued at $28.20M, down from 782,282 at the end of the previous reported quarter. Litespeed Management Llc who had been investing in Hain Celestial Group Inc. for a number of months, seems to be less bullish one the $2.85 billion market cap company. The stock decreased 2.63% or $0.71 during the last trading session, reaching $26.26. About 1.11 million shares traded. The Hain Celestial Group, Inc. (NASDAQ:HAIN) has declined 14.00% since May 20, 2017 and is downtrending. It has underperformed by 25.55% the S&P500.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on August, 7. They expect $0.75 EPS, up 11.94% or $0.08 from last year’s $0.67 per share. PFE’s profit will be $4.39 billion for 11.88 P/E if the $0.75 EPS becomes a reality. After $0.77 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -2.60% negative EPS growth.

Among 22 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 12 Hold. Therefore 41% are positive. Pfizer had 79 analyst reports since July 29, 2015 according to SRatingsIntel. S&P Research maintained the shares of PFE in report on Wednesday, October 28 with “Hold” rating. The firm earned “Market Perform” rating on Wednesday, January 31 by Leerink Swann. The stock has “Buy” rating by Jefferies on Thursday, July 14. BMO Capital Markets maintained Pfizer Inc. (NYSE:PFE) on Monday, June 12 with “Hold” rating. The stock of Pfizer Inc. (NYSE:PFE) has “Buy” rating given on Tuesday, September 5 by BMO Capital Markets. The firm has “Buy” rating by UBS given on Wednesday, November 1. Citigroup downgraded the shares of PFE in report on Tuesday, May 16 to “Sell” rating. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Jefferies on Monday, June 20. The stock of Pfizer Inc. (NYSE:PFE) earned “Neutral” rating by SunTrust on Wednesday, November 25. The firm has “Overweight” rating given on Tuesday, November 29 by Barclays Capital.

Gamco Investors Inc Et Al, which manages about $15.96B US Long portfolio, upped its stake in Loral Space & Communicatns Ico (NASDAQ:LORL) by 49,721 shares to 740,209 shares, valued at $32.61 million in 2017Q4, according to the filing. It also increased its holding in Big 5 Sporting Goods Corp Com (NASDAQ:BGFV) by 49,000 shares in the quarter, for a total of 213,000 shares, and has risen its stake in Lindsay Corp (NYSE:LNN).

Investors sentiment increased to 1.06 in Q4 2017. Its up 0.10, from 0.96 in 2017Q3. It is positive, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. Moody Savings Bank Trust Division invested in 98,930 shares or 0.17% of the stock. Bedell Frazier Invest Counseling Limited Liability Corporation has invested 2.5% in Pfizer Inc. (NYSE:PFE). Associated Banc holds 874,358 shares or 1.71% of its portfolio. 4.37 million are held by Teacher Retirement Systems Of Texas. Arcadia Invest Mngmt Corporation Mi holds 0.52% in Pfizer Inc. (NYSE:PFE) or 50,913 shares. Intll Sarl stated it has 0.15% of its portfolio in Pfizer Inc. (NYSE:PFE). Vantage Advsr Limited Liability Corporation invested in 162,148 shares or 1.35% of the stock. Optimum Inv holds 33,440 shares. Utah Retirement accumulated 1.10M shares or 0.84% of the stock. Dowling & Yahnke Limited Co reported 206,648 shares or 0.68% of all its holdings. Mathes Com holds 21,400 shares. 4.64M were accumulated by Natl Pension Serv. Gardner Russo Gardner Ltd Liability Com holds 0% of its portfolio in Pfizer Inc. (NYSE:PFE) for 1,900 shares. Charter Tru Company holds 1.14% of its portfolio in Pfizer Inc. (NYSE:PFE) for 270,028 shares. New York-based Mutual Of America Capital Mgmt Limited has invested 0.41% in Pfizer Inc. (NYSE:PFE).

Since December 15, 2017, it had 0 insider buys, and 13 insider sales for $17.75 million activity. $998,666 worth of stock was sold by JOHNSON RADY A on Tuesday, March 13. CORNWELL W DON sold $64,679 worth of Pfizer Inc. (NYSE:PFE) on Monday, February 26. Another trade for 69,699 shares valued at $2.55 million was made by Dolsten Mikael on Friday, March 9. 50,000 shares were sold by LANKLER DOUGLAS M, worth $1.84 million on Tuesday, March 13. 132,312 shares were sold by READ IAN C, worth $4.76 million on Tuesday, May 1. The insider SUSMAN SALLY sold 33,368 shares worth $1.24 million.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: 247Wallst.com which released: “What to Look For in the Merck and Pfizer Reports Tuesday Morning” on April 30, 2018, also Fool.com with their article: “Better Buy: Pfizer Inc. (PFE) vs. Merck (MRK)” published on May 13, 2018, Streetinsider.com published: “Pfizer (PFE) Says LYRICA Oral Solution CV Phase 3 Trial in Pediatric Epilepsy Met Primary Endpoint” on May 17, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Seekingalpha.com and their article: “Pfizer Is A Definite Buy For 2018” published on April 30, 2018 as well as Seekingalpha.com‘s news article titled: “Pfizer: Buy This Dip?” with publication date: May 03, 2018.

More important recent The Hain Celestial Group, Inc. (NASDAQ:HAIN) news were published by: Seekingalpha.com which released: “Profit pressure continues at Hain Celestial” on May 08, 2018, also Seekingalpha.com published article titled: “Opko Health Shouldn’t Be Down – Cramer’s Lightning Round (5/9/18)”, Streetinsider.com published: “Paulson’s 13F Shows New Stake in Goldcorp (GG), Increase in Discovery (DISCA), Viacom (VIAB) (more…)” on May 15, 2018. More interesting news about The Hain Celestial Group, Inc. (NASDAQ:HAIN) was released by: Globenewswire.com and their article: “Market Trends Toward New Normal in Viavi Solutions, Lattice Semiconductor, Abraxas Petroleum, American Outdoor …” with publication date: May 10, 2018.

Since February 28, 2018, it had 1 insider purchase, and 0 selling transactions for $49.02 million activity.

Among 30 analysts covering Hain Celestial Group (NASDAQ:HAIN), 11 have Buy rating, 2 Sell and 17 Hold. Therefore 37% are positive. Hain Celestial Group had 94 analyst reports since July 24, 2015 according to SRatingsIntel. Maxim Group maintained the shares of HAIN in report on Friday, November 6 with “Buy” rating. The firm has “Buy” rating given on Friday, June 9 by Jefferies. The rating was maintained by Maxim Group on Wednesday, January 13 with “Buy”. The company was maintained on Friday, October 6 by Bernstein. The firm earned “Neutral” rating on Friday, November 18 by Bank of America. The rating was maintained by Buckingham Research with “Neutral” on Wednesday, May 9. Maxim Group initiated The Hain Celestial Group, Inc. (NASDAQ:HAIN) on Friday, July 24 with “Buy” rating. As per Thursday, August 20, the company rating was maintained by Piper Jaffray. The firm has “Positive” rating by Susquehanna given on Tuesday, October 25. The firm earned “Neutral” rating on Friday, June 23 by JP Morgan.

Analysts await The Hain Celestial Group, Inc. (NASDAQ:HAIN) to report earnings on September, 4. They expect $0.26 earnings per share, down 39.53% or $0.17 from last year’s $0.43 per share. HAIN’s profit will be $28.18M for 25.25 P/E if the $0.26 EPS becomes a reality. After $0.37 actual earnings per share reported by The Hain Celestial Group, Inc. for the previous quarter, Wall Street now forecasts -29.73% negative EPS growth.

Investors sentiment increased to 1.11 in Q4 2017. Its up 0.24, from 0.87 in 2017Q3. It is positive, as 41 investors sold HAIN shares while 91 reduced holdings. 45 funds opened positions while 101 raised stakes. 90.39 million shares or 0.62% less from 90.96 million shares in 2017Q3 were reported. Ing Groep Nv holds 0.05% or 69,426 shares in its portfolio. Alliancebernstein Lp holds 0% or 67,023 shares in its portfolio. Northern Corporation invested 0.01% of its portfolio in The Hain Celestial Group, Inc. (NASDAQ:HAIN). Ameritas Invest Inc reported 30,957 shares stake. Texas Permanent School Fund stated it has 70,160 shares or 0.04% of all its holdings. Qs Ltd Liability Corp has invested 0% in The Hain Celestial Group, Inc. (NASDAQ:HAIN). Paragon Associate & Paragon Associate Ii Joint Venture has invested 1.41% in The Hain Celestial Group, Inc. (NASDAQ:HAIN). Strategic Ser Inc accumulated 75,103 shares or 0.5% of the stock. Amalgamated Bancorporation accumulated 0.02% or 20,579 shares. State Treasurer State Of Michigan holds 0.01% or 37,300 shares. Manufacturers Life Insurance Com The holds 0.01% of its portfolio in The Hain Celestial Group, Inc. (NASDAQ:HAIN) for 226,722 shares. Ftb Advsr owns 117 shares. Loring Wolcott Coolidge Fiduciary Advsr Llp Ma owns 588,033 shares for 0.46% of their portfolio. Mai Mgmt holds 0.02% or 7,126 shares in its portfolio. Hudson Bay Mngmt Limited Partnership accumulated 130,000 shares.

Litespeed Management Llc, which manages about $2.36 billion and $103.30 million US Long portfolio, upped its stake in R1 Rcm Inc. by 4.99M shares to 5.52M shares, valued at $24.34M in 2017Q4, according to the filing.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *